Skip to main content
. 2022 Feb 7;13:784054. doi: 10.3389/fnagi.2021.784054

TABLE 4.

Effect of the CR marker on cognitive decline and disease severity (95% confidence intervals from bootstrapping).

AD spectrum
CU
95% CIs of β values 95% CIs of β values
MMSE
CR marker −0.17 ∼ 3.01 0.17 ∼ 1.67
Time −0.16 ∼−0.08 −0.05 ∼ 0.01
CR marker × Time −0.08 ∼−0.006 0.01 ∼ 0.07
Composite score
CR marker 2.00 ∼ 8.50 3.47 ∼ 7.47
Time −0.28 ∼−0.12 −0.26 ∼−0.09
CR marker × Time −0.15 ∼−0.007 0.13 ∼ 0.27
Memory score
CR marker 1.23 ∼ 14.39 4.31 ∼ 13.79
Time −0.38 ∼−0.11 −0.75 ∼−0.22
CR marker × Time −0.27 ∼−0.01 0.14 ∼ 0.62
CDR-SB
CR marker −1.64 ∼ 0.27 −0.64 ∼ 0.42
Time 0.04 ∼ 0.10 −0.01 ∼ 0.06
CR marker × Time 0.003 ∼ 0.06 −0.05 ∼ 0.01

AD spectrum, Alzheimer’s disease spectrum; CU, cognitively unimpaired group; MMSE, Mini-Mental State Examination; Composite score, the average score of five domains; CDR-SB, Clinical Dementia Rating Scale-Sum of Boxes; β, beta coefficient of each variable; CI, 95% confidence interval of the beta coefficient.